SANUWAVE Health, Inc. Business Acquisition, Pro Forma Revenue
SANUWAVE Health, Inc. (SNWV) reported Business Acquisition, Pro Forma Revenue of $7.80 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-05-13.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2022-05-13
- SANUWAVE Health, Inc. business acquisition, pro forma revenue for the quarter ending 2020-12-31 was $1.83M, a 16.72% decline year-over-year.
- SANUWAVE Health, Inc. business acquisition, pro forma revenue for the quarter ending 2020-09-30 was $2.77M, a 19.13% increase year-over-year.
- SANUWAVE Health, Inc. business acquisition, pro forma revenue for the quarter ending 2019-12-31 was $2.19M.
- SANUWAVE Health, Inc. business acquisition, pro forma revenue for the quarter ending 2019-09-30 was $2.33M.
- SANUWAVE Health, Inc. business acquisition, pro forma revenue for fiscal 2020 was $7.80M, a 13.37% decline from fiscal 2019.
- SANUWAVE Health, Inc. business acquisition, pro forma revenue for fiscal 2019 was $9.00M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $1.83M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-13 | $4.60M derived: sum of 2 quarters · filed 2022-05-13 | $7.80M 10-K · filed 2022-05-13 | $7.83M 10-K · filed 2021-10-21 | |
| 2020-09-30 | $2.77M 10-Q/A · filed 2021-07-01 | $5.97M 10-Q/A · filed 2021-07-01 | |||
| 2019-12-31 | $2.19M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-10-21 | $4.52M derived: sum of 2 quarters · filed 2021-10-21 | $9.00M 10-K · filed 2021-10-21 | ||
| 2019-09-30 | $2.33M 10-Q/A · filed 2021-07-01 | $6.81M 10-Q/A · filed 2021-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |